Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $17.9 Million - $25 Million
-321,560 Reduced 51.09%
307,885 $19.1 Million
Q3 2023

Nov 14, 2023

SELL
$60.27 - $90.75 $18.7 Million - $28.1 Million
-309,469 Reduced 32.96%
629,445 $43.7 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $21.5 Million - $26 Million
260,863 Added 38.47%
938,914 $78.8 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $322,236 - $559,056
-6,747 Reduced 0.99%
678,051 $56 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $11 Million - $17.5 Million
225,707 Added 49.16%
684,798 $34.9 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $1.58 Million - $2.22 Million
25,700 Added 5.93%
459,091 $32.3 Million
Q2 2022

Aug 15, 2022

BUY
$55.54 - $72.65 $24.1 Million - $31.5 Million
433,391 New
433,391 $28.6 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.1B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.